Inactive Instrument
Ceapro Inc. Stock
Stocks
CZO
CA1499071076
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -11.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 72 | 2012-06-20 |
| Director of Finance/CFO | - | - | |
Michael Teifel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
BRD | Director/Board Member | 72 | 2006-12-31 |
William Li
BRD | Director/Board Member | 63 | 2014-11-19 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 2015-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/7/24 | Marche | Director | 210,000 | 0.2682% | ||
| 6/7/24 | Marche | Director | 230,000 | 0.2938% | ||
| 6/7/24 | Marche | Chief Executive Officer | 700,000 | 0.8941% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -11.76% | -16.67% | - | - | 12.8M | ||
| -2.54% | -2.84% | -1.90% | +14.52% | 50.35B | ||
| -0.40% | +1.03% | +439.20% | +499.20% | 45.2B | ||
| -1.42% | +2.30% | +45.46% | +19.36% | 44.71B | ||
| -1.22% | -2.31% | +12.40% | +71.48% | 41.24B | ||
| +0.53% | -1.36% | +16.04% | +48.23% | 33.08B | ||
| -0.21% | +9.14% | - | - | 17.81B | ||
| -0.35% | -1.56% | +22.59% | +116.19% | 16.56B | ||
| -1.01% | +0.50% | +15.83% | +27.98% | 14.82B | ||
| -1.65% | -1.03% | +77.75% | +37.63% | 14B | ||
| Average | -2.00% | +0.49% | +78.42% | +104.33% | 30.86B | |
| Weighted average by Cap. | -1.04% | +0.26% | +94.35% | +121.44% |
Employees
-
















